by John T Murphy, MSOL, RRT, CPFT
The following summary is a list of recent articles or online publications and releases that involve news about Respiratory Therapy concerns, focus, disease management, prevention and care.
|COPD Morbid-ity Linked to Omega Fatty Acid Intake||December 6, 2019||Sheila Jacobs||Annals of the ATS||https://www.pulmonologyadvisor.com/home/topics/copd/chronic-obstructive-pulmonary-disease-exacerbations-and-omega-3-and-6-fatty-acids/||Higher total omega-3 intake was linked to fewer severe COPD exacerbations and a trend toward higher lung function.|
|More E-Cigarette Users Starting Before Age 14||December 24, 2019||Lisa Rapaport||Reuters Health||https://www.managedhealthcareconnect.com/content/more-e-cigarette-users-starting-age-14||The article says that the percentage of vapers who started by 14 increased “from just 8.8% in 2014…to 28.6% in 2018.|
|Mucin 1 protein may trigger profibrotic transformations in the lungs that contribute to IPF, study suggests||December 23, 2019||Ana Pena||PF News||https://pulmonaryfibrosisnews.com/2019/12/29/mucin-1-protein-therapeutic-target-ipf-study/||The study’s findings were published in Thorax and suggest that MUC1 may be a therapeutic target for the treatment of IPF.|
|Evidence mounts that vitamin E acetate is to blame for vaping-related illnesses, deaths||December 20, 2019||Lena Sun||Washington Post||https://www.washingtonpost.com/health/2019/12/20/evidence-mounts-that-vitamin-e-acetate-is-blame-vaping-related-illnesses-deaths/||CDC releases four new reports on vaping-related lung illnesses concerning current state of outbreak, vitamin E acetate, risk of relapse, and other matters.|
|Long-term study: E-cigarettes increase risk for chronic lung diseases||December 19, 2019||Bhatta DN, Glantz SA||American Journal of Preventive Medicine||https://www.ajpmonline.org/article/S0749-3797(19)30391-5/fulltext||Current use of e-cigarettes appears to be an independent risk factor for respiratory disease in addition to all combustible tobacco smoking.|